Boris Gorovits

4.2k total citations
76 papers, 2.5k citations indexed

About

Boris Gorovits is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Boris Gorovits has authored 76 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Immunology, 46 papers in Molecular Biology and 44 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Boris Gorovits's work include Biosimilars and Bioanalytical Methods (44 papers), Monoclonal and Polyclonal Antibodies Research (44 papers) and CAR-T cell therapy research (16 papers). Boris Gorovits is often cited by papers focused on Biosimilars and Bioanalytical Methods (44 papers), Monoclonal and Polyclonal Antibodies Research (44 papers) and CAR-T cell therapy research (16 papers). Boris Gorovits collaborates with scholars based in United States, United Kingdom and Switzerland. Boris Gorovits's co-authors include Paul M. Horowitz, Eugen Koren, Viswanath Devanarayan, Deborah Finco‐Kent, Holly W. Smith, Gopi Shankar, Linda A. Zuckerman, Valerie Quarmby, Michael Moxness and Michele Fiscella and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Boris Gorovits

73 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Gorovits United States 26 1.2k 1.2k 1.1k 731 214 76 2.5k
Radka Saldova Ireland 33 3.2k 2.5× 776 0.7× 1.1k 1.0× 412 0.6× 167 0.8× 87 3.8k
Michael G. Mulkerrin United States 18 1.6k 1.3× 898 0.8× 569 0.5× 315 0.4× 344 1.6× 24 2.7k
Linda K. Jolliffe United States 31 1.5k 1.2× 815 0.7× 959 0.8× 780 1.1× 520 2.4× 60 3.7k
Dhaval K. Shah United States 31 1.1k 0.9× 1.3k 1.1× 425 0.4× 1.1k 1.5× 145 0.7× 109 2.7k
Lei Zhou China 33 1.9k 1.5× 267 0.2× 596 0.5× 656 0.9× 126 0.6× 110 3.3k
Zahra Shahrokh United States 15 2.6k 2.1× 492 0.4× 730 0.6× 565 0.8× 176 0.8× 26 3.2k
Claudia De Lorenzo Italy 29 929 0.7× 589 0.5× 430 0.4× 897 1.2× 139 0.6× 88 2.1k
Ruud P.M. Dings United States 35 2.3k 1.9× 299 0.3× 1.3k 1.1× 955 1.3× 93 0.4× 74 3.7k
Lawren C. Wu United States 31 1.1k 0.9× 307 0.3× 2.1k 1.8× 487 0.7× 100 0.5× 46 4.7k
J. Jay Boniface United States 22 1.9k 1.5× 975 0.8× 3.3k 2.9× 827 1.1× 141 0.7× 48 5.4k

Countries citing papers authored by Boris Gorovits

Since Specialization
Citations

This map shows the geographic impact of Boris Gorovits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Gorovits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Gorovits more than expected).

Fields of papers citing papers by Boris Gorovits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Gorovits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Gorovits. The network helps show where Boris Gorovits may publish in the future.

Co-authorship network of co-authors of Boris Gorovits

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Gorovits. A scholar is included among the top collaborators of Boris Gorovits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Gorovits. Boris Gorovits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braun, Manuela, Claudia Lange, Philipp Schatz, et al.. (2024). Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements. Molecular Therapy — Methods & Clinical Development. 32(1). 101217–101217. 11 indexed citations
2.
3.
Joyce, Alison, et al.. (2022). Determination of Anti-drug Antibody Affinity in Clinical Study Samples Provides a Tool for Evaluation of Immune Response Maturation. The AAPS Journal. 24(6). 114–114. 9 indexed citations
4.
5.
Gorovits, Boris, George Buchlis, Travis Harrison, et al.. (2021). Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays. The AAPS Journal. 23(6). 108–108. 32 indexed citations
6.
Smith, Judith F., et al.. (2020). Development of a Highly Specific Anti-drug Antibody Assay in Support of a Nanoparticle-based Therapeutic. The AAPS Journal. 22(4). 81–81.
7.
Gorovits, Boris. (2020). Current Considerations for Immunoglobulin Isotype Characterization of Antibody Response against Biotherapeutics. The AAPS Journal. 22(6). 144–144. 14 indexed citations
8.
Gorovits, Boris, Michele Fiscella, Eugen Koren, et al.. (2020). Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays. The AAPS Journal. 22(2). 24–24. 35 indexed citations
9.
Myler, Heather, Boris Gorovits, Viswanath Devanarayan, et al.. (2019). Report on the AAPS Immunogenicity Guidance Forum. The AAPS Journal. 21(4). 55–55. 14 indexed citations
10.
11.
Gorovits, Boris, et al.. (2019). Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data Analysis. The AAPS Journal. 21(5). 76–76. 2 indexed citations
12.
13.
Gorovits, Boris, Adrienne Clements‐Egan, Mary Birchler, et al.. (2016). Pre-existing Antibody: Biotherapeutic Modality-Based Review. The AAPS Journal. 18(2). 311–320. 57 indexed citations
14.
Sailstad, Jeffrey, Lakshmi Amaravadi, Adrienne Clements‐Egan, et al.. (2014). A White Paper—Consensus and Recommendations of a Global Harmonization Team on Assessing the Impact of Immunogenicity on Pharmacokinetic Measurements. The AAPS Journal. 16(3). 488–498. 48 indexed citations
15.
Gorovits, Boris. (2009). Antidrug Antibody Assay Validation: Industry Survey Results. The AAPS Journal. 11(1). 133–138. 24 indexed citations
16.
Gorovits, Boris, et al.. (1997). Conditions for Nucleotide-dependent GroES-GroEL Interactions. Journal of Biological Chemistry. 272(43). 26999–27004. 10 indexed citations
17.
Gibbons, Don L., et al.. (1996). Intrinsic Fluorescence Studies of the Chaperonin GroEL Containing Single Tyr → Trp Replacements Reveal Ligand-induced Conformational Changes. Journal of Biological Chemistry. 271(50). 31989–31995. 9 indexed citations
18.
Gorovits, Boris, et al.. (1995). Residual Structure in Urea-Denatured Chaperonin GroEL. Biochemistry. 34(42). 13928–13933. 23 indexed citations
19.
Gorovits, Boris, C.S. Raman, & Paul M. Horowitz. (1995). High Hydrostatic Pressure Induces the Dissociation of cpn60 Tetradecamers and Reveals a Plasticity of the Monomers. Journal of Biological Chemistry. 270(5). 2061–2066. 56 indexed citations
20.
Choi, Myung Ja, et al.. (1994). A Visual Membrane Immunoassay for the Detection of Methamphetamine Using an Enzyme-Labeled Tracer Derived from Methamphetamine and Amphetamine.. Biological and Pharmaceutical Bulletin. 17(7). 875–880. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radka Saldova Breakdown of academic impact, for papers by Michael G. Mulkerrin Breakdown of academic impact, for papers by Linda K. Jolliffe Breakdown of academic impact, for papers by Dhaval K. Shah Breakdown of academic impact, for papers by Lei Zhou Breakdown of academic impact, for papers by Zahra Shahrokh Breakdown of academic impact, for papers by Claudia De Lorenzo Breakdown of academic impact, for papers by Ruud P.M. Dings Breakdown of academic impact, for papers by Lawren C. Wu Breakdown of academic impact, for papers by J. Jay Boniface
Rankless by CCL
2026